Based on 2 analysts giving stock ratings to Helius Medical Technologies Inc in the past month.
In the current month, HSDT has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HSDT average Analyst price target in the last month is 3.250.
Based on analysts' estimates, HSDT EPS is projected to reach 0.005 in FY2026Q3, following reported EPS of -0.379 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.38, while Helius Medical Technologies IncHSDT's earnings per share (EPS) for the previous quarter was USD -1.30. EPS for the next quarter is expected at USD 0.01.